Sivu 1 alkaen 122 tuloksia
BACKGROUND
Lysyl oxidases (LOX, LOXL, LOXL2, etc.; amine oxidase family) are Cu-dependent enzymes that oxidize lysine into allysine (.alpha.-aminoadipic-.delta.-semialdehyde) [Kagan H M. et al., J. Cell. Biochem. 2003; 88:660]. LOX have been implicated in crosslink formation in stromal collagens and
TECHNICAL FIELD
This invention pertains to polyamine compounds, including polyamine/guanidine and polyamine/biguanide compounds, useful for treatment of cancer and/or parasitic infections, and for inhibition of lysine-specific demethylase.
BACKGROUND
Polyamines are found in both eukaryotic and
TECHNICAL FIELD
The present invention provides compounds that are capable of modulating the activity of histone lysine demethylase (KDM), pharmaceutical compositions thereof, methods to prepare the said compounds, and the use of such compounds as a medicament.
BACKGROUND
The nucleosome is a basic
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Stage Filing under 35 U.S.C. 371 from International Application No. PCT/SG2013/000490, entitled "METHOD OF TREATING CANCER," filed on month Nov. 19, 2013, and published as WO 2014/077784 A1 on May 22, 2014, which claims the
INCORPORATION BY REFERENCE OF MATERIAL IN ASCII TEXT FILE
This application incorporates by reference the Sequence Listing contained in the following ASCII text file being submitted concurrently herewith:
a) File name: TDQ-10021_SEQLISTING.txt; created Feb. 1, 2018, 28 KB in size.
BACKGROUND OF THE
INCORPORATION BY REFERENCE OF MATERIAL IN ASCII TEXT FILE
This application incorporates by reference the Sequence Listing contained in the following ASCII text file being submitted concurrently herewith:
a) File name: 48051000017SEQLISTING.txt; created Jan. 6, 2014, 28 KB in size.
BACKGROUND OF THE
INCORPORATION BY REFERENCE OF MATERIAL IN ASCII TEXT FILE
This application incorporates by reference the Sequence Listing contained in the following ASCII text file being submitted concurrently herewith:
a) File name: 48051000006SeqListing,txt; created Jun. 11, 2013, 28 KB in size.
BACKGROUND OF THE
REFERENCE TO SEQUENCE LISTING
The Sequence Listing submitted Nov. 30, 2015 as a text file named "37474_0004U3_Sequence_Listing.txt", created on Nov. 30, 2015, and having a size of 82,955 bytes is hereby incorporated by reference pursuant to 37 C.F.R. .sctn. 1.52(e)(5).
BACKGROUND
The official name
TECHNICAL FIELD
The invention provides for novel (bis)urea and (bis)thiourea compounds which are inhibitors of lysine-specific demethylase 1 (LSD1). Such compounds may be used to treat disorders, including cancer.
BACKGROUND OF THE INVENTION
Chromatin architecture is a key determinant in the
BACKGROUND OF THE INVENTION
The present application claims the priority benefit of U.S. provisional application No. 61/871,688, filed Aug. 29, 2013, the entire contents of which are incorporated herein by reference.
The sequence listing that is contained in the file named "MESCP0078US_ST25. txt",
BACKGROUND
A need exists in the art for an effective treatment of cancer and neoplastic disease.
BRIEF SUMMARY OF THE INVENTION
Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are
BACKGROUND
A need exists in the art for an effective treatment of cancer and neoplastic disease.
BRIEF SUMMARY OF THE INVENTION
Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are
BACKGROUND
A need exists in the art for an effective treatment of cancer and neoplastic disease.
BRIEF SUMMARY OF THE INVENTION
Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are
BACKGROUND
A need exists in the art for an effective treatment of cancer and neoplastic disease.
BRIEF SUMMARY OF THE INVENTION
Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are
BACKGROUND
A need exists in the art for an effective treatment of cancer and neoplastic disease.
BRIEF SUMMARY OF THE INVENTION
Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are